Clinical Response to Tumor Necrosis Factor- α Inhibitor Therapy in the Management of Cardiac Sarcoidosis

This study aimed to evaluate the disease course of patients with CS treated with either infliximab or adalimumab the rapy based on serial 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) imaging and clinical outcomes. An institutional CS research database was queried for patients treated with TNF-α inhibitors between 2016 and 2021.

Source: The American Journal of Cardiology - August 12, 2023 Category: Cardiology Authors: Robert Churchill, Daniel Sykora, Matteo Castrichini, Courtney Arment, Elena Myasoedova, Mohamed Elwazir, John Bois, Kathleen Young, Andrew Rosenbaum Source Type: research